Linden Thomas Advisory Services’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$285K Sell
924
-2
-0.2% -$620 0.02% 496
2026
Q2
$259K Buy
926
+10
+1% +$2.63K 0.02% 499
2026
Q1
$244K Sell
916
-23
-2% -$6.23K 0.02% 499
2025
Q4
$236K Sell
939
-14
-1% -$3.72K 0.02% 463
2025
Q3
$274K Sell
953
-10
-1% -$2.68K 0.03% 427
2025
Q2
$253K Sell
963
-48
-5% -$11.7K 0.03% 435
2025
Q1
$235K Buy
1,011
+20
+2% +$4.85K 0.03% 442
2024
Q4
$227K Sell
991
-15
-1% -$3.44K 0.03% 451
2024
Q3
$225K Buy
+1,006
New +$221K 0.03% 449

Other funds holding LH

Linden Thomas Advisory Services's LH Position: Q3 2026 in Review

Linden Thomas Advisory Services reduced its Labcorp (LH) stake by 0.22% in Q3 2026, selling an estimated $620 and leaving 924 shares worth $285K. The position accounts for 0.02% of the portfolio, ranked #496.

Linden Thomas Advisory Services first reported a position in LH in Q3 2024 and has held it in 9 quarters since. 278 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Linden Thomas Advisory Services held 924 shares of Labcorp worth $285K as of Q3 2026.
  • Linden Thomas Advisory Services sold 2 Labcorp shares in Q3 2026, an estimated $620.
  • Labcorp made up 0.02% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #496 holding.
  • Linden Thomas Advisory Services first reported a position in Labcorp in Q3 2024 and has held it in 9 quarters since.
  • 278 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.